Healthcare M&A hit three-year low in Q2, report finds
Continuing financial pressures could keep deal-making low in the second half of the year, but M&A could heat up in early 2024, a new KPMG report finds.
Continuing financial pressures could keep deal-making low in the second half of the year, but M&A could heat up in early 2024, a new KPMG report finds.
Star ratings bonuses jumped 30% from 2022 to 2023 to reach $12.8 billion, according to the KFF, as the Medicare program faces a growing spending crisis.
The nation’s largest for-profit operators posted revenue results that beat Wall Street expectations on rebounding patient demand, and reported progress on labor initiatives.
The study, published in Health Affairs, found large national insurers had higher price ratios than other payers.
Hospital CEO turnover remained depressed last year, according to one report, but separate research suggests executive changes were on the rise as of June.
Clover notched its first quarterly adjusted EBITDA profit as a public company, while Oscar reached total company profitability for the second quarter in a row. Meanwhile, Bright posted its first quarter ever with positive adjusted EBITDA.
The letter, sent by a bipartisan group of senators to tax commissioners, comes as the federal government increases scrutiny into nonprofit hospitals’ charity care spending.
The complexity of combining IT systems and increased media attention before a deal could explain hospitals’ increased vulnerability, according to the paper.
Albert Marinez, who previously held a similar role at Intermountain Health, will focus on cutting costs and using data to improve patient care.
UnitedHealth, CVS, Elevance and peers sidestepped the worst of medical cost growth in the quarter, but many payers face uncertainty from Medicare Advantage star ratings, GLP-1s and other pressures.